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ABSTRACT The vertebrate Scube (Signal peptide, CUB, and EGF-like domain-containing protein) family
consists of three independent members, Scube1–3, which encode secreted cell surface-associated membrane
glycoproteins. Limited information about the general function of this gene family is available, and their roles
during adulthood. Here, we present the ﬁrst Scube3 mutant mouse line (Scube3N294K/N294K), which clearly
shows phenotypic alterations by carrying a missense mutation in exon 8, and thus contributes to our un-
derstanding of SCUBE3 functions. We performed a detailed phenotypic characterization in the GermanMouse
Clinic (GMC). Scube3N294K/N294K mutants showed morphological abnormalities of the skeleton, alterations of
parameters relevant for bone metabolism, changes in renal function, and hearing impairments. These ﬁndings
correlate with characteristics of the rare metabolic bone disorder Paget disease of bone (PDB), associated with
the chromosomal region of human SCUBE3. In addition, alterations in energy metabolism, behavior, and
neurological functions were detected in Scube3N294K/N294K mice. The Scube3N294K/N294K mutant mouse line
may serve as a new model for further studying the effect of impaired SCUBE3 gene function.
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The vertebrate Scube (Signal peptide, CUB and EGF-like domain-
containing protein) family consists of three independent members,
Scube1–3. These encode secreted cell surface-associated glycoproteins
that share a domain, organization of at least ﬁve recognizable motifs
and the ability to both homo- and heterodimerize (Xavier et al. 2013).
Human SCUBE3 was originally identiﬁed following transcriptional
proﬁling of vascular endothelial cells and demonstrated signiﬁcant
enrichment in primary osteoblasts and long bones (Wu et al. 2004).
SCUBE3 is a signal protein that is expressed during embryonic de-
velopment in several tissues (Xavier et al. 2013). In mice, Scube3 is
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expressed in ectodermal, endodermal, and mesodermal derivatives,
as are other members of the Scube gene family (Haworth et al. 2007).
Expression of these genes has been shown to be dynamic, and both
reciprocal and complementary to each other (Xavier et al. 2013;
Haworth et al. 2007).
Although our understanding of the function of SCUBE3 in embry-
onic development as well as during adulthood is still marginal, one
major role appears to be in bone development and homeostasis, with
another one in neurological functions. Interestingly, human SCUBE3
maps to chromosome 6p21.3, a region that has been linked to Paget
disease of bone 1 (PDB1) (Fotino et al. 1977; Tilyard et al. 1982), which
is characterized by focal areas of increased bone turnover (Ralston et al.
2008). SCUBE3 function is also associated with other tissues, for exam-
ple, Scube3 overexpression in transgenic mice induced cardiac hyper-
trophy (Yang et al. 2007), and zebraﬁsh Scube3 was recently identiﬁed
as a key regulator of fast muscle development by modulating ﬁbroblast
growth factor signaling (Tu et al. 2014). Further associations of Scube3
have been reported with hedgehog signal transduction (Johnson et al.
2012), angiogenesis (Yang et al. 2013), and the immune system (Luo
et al. 2012). In addition, deregulation of SCUBE3 has been found in
different tumor tissues such as lung cancer (Wu et al. 2011; Zhao et al.
2013) or renal carcinomas (Morris et al. 2011).
Although SCUBE3 seems to be involved in many different organ
systems and diseases, there is no suitable mouse model so far for the
study of functional alterations. Recent publications on mice lacking
Scube3 did not show any obvious phenotype (Xavier et al. 2010; Xavier
et al. 2013). In this study, we present the ﬁrst Scube3mutant mouse line
with phenotypic alterations: Scube3N294K/N294K. The mutant mouse line
carries a recessive point mutation in Scube3 and was derived from the
MunichN-ethyl-N-nitrosourea (ENU) mouse mutagenesis project
(MEP, Hrabé de Angelis et al. 2000; Sabrautzki et al. 2012). A
systemic phenotypic characterization (Hrabé de Angelis et al. 2015)
of this new mutant mouse line annotates Scube3 gene function in mice
to bone metabolism and morphology, renal function, and hearing, as
well as neurological and behavioral functions and energy metabolism.
MATERIALS AND METHODS
Generation of Scube3N294K/N294K mutants
ENUmutagenesis and breeding were performed as described on a pure
C3HeB/FeJ (C3H) background (Hrabé de Angelis et al. 2000; Sabrautzki
et al. 2012; Aigner et al. 2011). Brieﬂy, C3H mice were originally pur-
chased from the Jackson Laboratory (Bar Harbor, ME) and ENU (Serva
Electrophoresis, Heidelberg, Germany) was applied in three weekly in-
tervals by intraperitoneal injections of 90mg/kg body weight to 10–12wk
old male mice (G0). G0 mice were mated with wild-type C3H females to
produce F1 offspring. F1 males not showing any obvious phenotypic
alterations were mated with wild-type C3H females to obtain the G2
generation. We either choose 6–8 female G2 mice for matings with their
F1 father or performed intercross matings of G2 mice to produce at least
20 mice (G3 families). Phenotyping for dysmorphological alterations was
performed according to a standardized protocol (Fuchs et al. 2000). A
mutation was conﬁrmed by showing aMendelian distribution of expected
homozygous mutant mice. The Scube3N294K/N294K mouse line was main-
tained on the C3H genetic background for more than 10 generations.
Chromosomal mapping
Homozygous carriersof theG3generationweremated toC57BL/6J (B6)
wild-typemice and theprogeny(F1generation)were intercrossed.DNA
was prepared from tail tips of affected offspring (F2 generation). For
chromosomalmapping, amicrosatellite panel for polymorphicmarkers
between C3H and B6 was used (Hrabé de Angelis et al. 2000).
Whole exome sequencing
For enrichment of exonic sequences, we used the SureSelectXT Mouse
All Exon 50Mb kit (Agilent) followed by Illumina HiSeq2000 sequenc-
ing as 100 bppaired-end runswith an average 108· coverage (. 93%of
the target being covered . 20 ·). To search for the causative variants,
we compared the sequences of one Scube3N294K/N294K mouse to one
mouse from the C3HeB/FeJ background strain.
Phenotypic analysis
For the phenotypic characterization of young adult (starting at the ageof
7 wk) Scube3N294K/N294K mutants, a cohort of 15 male and 15 female
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Scube3N294K/N294K mutants, as well as 15 male and 15 female wild-type
littermate controls (Scube3WT), was analyzed in the primary phe-
notyping screen of the GMC (Hrabé de Angelis et al. 2015; Gailus-
Durner et al. 2005; Fuchs et al. 2012, 2011). The tests within the
phenotyping pipeline and the corresponding age of the animals, as
well as references for the protocols, are shown in Supplemental
Material, Table S1. For further detailed investigation of observed
phenotypes, secondary tests were carried out. Details for the ap-
plied protocols are listed below.
Progression study
Since Scube3N294K/N294K mice showed signs of an impaired bone
metabolism, we tested groups of Scube3N294K/N294K and Scube3WT
mice at 12, 24, 36, and 52 wk of age for the clinical chemical plasma
parameters inorganic calcium (Ca), total inorganic phosphate (Pi),
total alkaline phosphatase (ALP), cholesterol (CHO), triglycerides
(TGL), glucose (GLUC), total protein (TP), urea (U), uric acid (UA),
and albumin (ALB) by using an AU480 clinical chemistry analyzer
(Beckman-Coulter, Krefeld, Germany) and adapted reagent kits
provided by Beckman-Coulter. Additionally, pQCT (peripheral Quan-
titative Computed Tomography, Stratec, Pforzheim, Germany) analy-
ses of the femoral metaphysis and diaphysis were performed at the age
of 9 and 12 months. We measured CTX-1 in plasma of 52 wk old mice
using RatLaps (carboxy-terminal collagen crosslinks, CTX-1) EIA
ELISA from IDS (Frankfurt am Main, Germany) according to the
manufacturer’s protocol.
Analysis of renal function in metabolic cages
A subgroup of 48 animals (12 mutant and control mice each of both
sexes) at the age of 34 wk was subjected to a renal function test using
metabolic cages for single mice (Tecniplast, Buguggiate, Italy) to collect
48hrurinesamplesandmonitorwaterandurineproduction.During the
test, mice had free access to water and pulverized food. Tests were
conducted as described previously, starting with a single blood sample
collection followed by urine collection over 48 hr (Fuchs et al. 2011).
Urine and plasma samples were analyzed for a set of 12 clinical chem-
istry parameters including concentrations of sodium, potassium, and
chloride (Na, K, and Cl), Ca, Pi, creatinine (CREA), U, UA, and GLUC,
as well as TP and ALB, as described above.
Transcriptome analysis
Transcriptome analyses from kidney samples of four Scube3N294K/N294K
and four Scube3WT male mice at the age of 29 wk were performed
following total RNA extraction (RNAeasyMidi kit, QIAGEN). Illumina
Mouse Ref8 v2.0 Expression BeadChips were employed as previ-
ously described (Horsch et al. 2008; Kugler et al. 2013). Illumina
Genomestudio 2011.1 was used for data normalization (cubic
spline) and statistical analysis for the identiﬁcation of differential
gene expression was performed with SAM (Signiﬁcant Analysis of
Microarrays, fold change . 1.6, FDR , 6%) (Saeed et al. 2006;
Tusher et al. 2001). Overrepresented functional annotations were
obtained through the use of QIAGEN’s Ingenuity Pathway Analysis
(IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity). Ex-
pression data are available at the GEO database under GSE56402.
Inner ear preparation
Inner ears were dissected from the temporal bones of killed animals and
ﬁxed in 4% formalin (Carl Roth GmbH, Karlsruhe, Germany). Follow-
ing dehydration in ethanol, inner ears were immersed in methyl
salicylate (Sigma Aldrich, Taufkirchen, Germany) and incubated over-
night. Analysis of cleared inner ears was documented by photographic
images.
Figure 1 Skeletal abnormalities in Scube3N294K/N294K
mice. (A) Femur length of female animals plotted
by body length (red, Scube3N294K/N294K and
blue, Scube3WT. (B) Bone mineral content plot-
ted by body weight (green, Scube3N294K/N294K
males; yellow, Scube3N294K/N294K females;
blue, Scube3WT males; and red, Scube3WT fe-
males). (C) Bone mineral content plotted by
body weight (green, Scube3N294K/N294K males;
yellow, Scube3N294K/N294K females; blue, Scube3WT
males; red, Scube3WT females).
Volume 6 December 2016 | Scube3 Mutant Mouse Phenotype | 4037
Feces analysis
Fecal sampleswerecollected insingle cagedmice forconsecutive5d.Feces
were separated fromothermaterial (beddingandfood)anddesiccated ina
drying oven at 60 until weight constancy before bomb calorimetric
combustion (IKA C7000, Staufen, Germany). Calorie content of food
samples was also determined by bomb calorimetry. Energy uptake was
calculated by multiplying food energy content and total amount of food
consumed. Egested energy was calculated from feces energy content
multiplied by the amount of egested feces (see also Rozman et al. 2014).
Statistical analysis
The Shapiro–Wilk test, as well as histograms and quantile–quantile
plots, were used to assess the normality of the investigated parameters.
For continuous data meeting the assumption of normality, a two-way
ANOVA with a Tukey HSD post hoc test or a linear model (including
body weight as an additional covariate in some cases) was performed to
test genotype–sex interaction effects. In tables, normally distributed
data were expressed as means 6 SDs. Parameters with a skewed dis-
tribution were analyzed using the nonparametric Wilcoxon rank sum
test and were presented as median as well as 25th percentile and 75th
percentile in the tables. Categorical parameters were analyzed by a
Fisher’s exact test and are presented as absolute numbers. For all tests,
a P-value, 0.05 was used as the level of signiﬁcance. Since the primary
phenotyping screen in the GMC was mainly designed as a high-
throughput screen for new phenotypic alterations, a correction for
multiple testing of the various parameters was not performed.
Data were analyzed using R software (Version 3.0.2; Foundation
of Statistical Computing, Vienna, Austria).
Housing andhandling ofmicewas according to theGermanAnimal
Welfare Act. The animal experiments were approved by the Govern-
ment of Upper Bavaria (112-02, 78-06, 144-10, and 126-11).
Data availability
Data of the complete phenotypic analysis is accessible via the website of
the GMC (http://tools.mouseclinic.de/phenomap/jsp/annotation/
public/phenomap.jsf), and the Scube3N294K/N294Kmutant mouse line
is accessible via the European Mouse Mutant Archive (EMMA,
www.infrafrontier.eu) under EMMA ID EM:10872.
RESULTS
Generation of Scube3N294K/N294K mice
The Scube3N294K/N294K mutation was generated in the large-scale
Munich ENU mutagenesis program. The mutant line was identiﬁed
by screening G3 animals for morphological abnormalities resulting
in reduced body size (Figure 1A), a shorter and kinky tail, abnormal
digit positioning, and an abnormal posture when hung by the tail.
Scube3N294K/N294K variants were crossed to wild-type C3HeB/FeJ
(C3H) mice, and none of the offspring showed the characteristic
Scube3N294K/N294K phenotypes. However, intercrossing these hetero-
zygous mice resulted in a fraction of about 25% of offspring that
showed the characteristic Scube3N294K/N294K phenotypes. Therefore,
we considered Scube3N294K/N294K to be a recessive mutant mouse line,
and maintained the mutation on a pure C3H genetic background for
more than 10 generations.
Mutation detection
Rough mapping by an outcross/intercross breeding strategy with
C57BL/6J (B6) animals revealed a 12.4 Mb critical region on chromo-
some 17 between markers D17Mit46 and D17Mit34, with no recombi-
nants near marker D17Mit198. Whole exome sequencing identiﬁed a
homozygous nonsynonymous sequence variation within the Scube3
gene, the only candidate genewithin the critical region on chromosome
Figure 2 Statistically signiﬁcantly changed clinical chemical and CTX-1 plasma values of aged groups of Scube3N294K/N294K mice measured at 12,
24, 36, and 52 wk of age. Red or blue ﬁlled arrows show signiﬁcantly increased or decreased plasma values for female and male mice compared to
Scube3WT mice ( P # 0.05, P = 0.01, P # 0.001; nt = not tested). Unshaded but red or blue outlined arrows show a tendency to increased or
decreased values not reaching statistically signiﬁcance. Numbers of mice at 12 wk were female Scube3N294K/N294K mice n = 9, female Scube3WT
n = 20, male Scube3N294K/N294K mice n = 21, and male Scube3WT n = 34; at 24 wk female Scube3N294K/N294K mice n = 10, female Scube3WT n = 21,
male Scube3N294K/N294K mice n = 15, and male Scube3WT n = 29; at 36 wk female Scube3N294K/N294K mice n = 12, female Scube3WT n = 8, male
Scube3N294K/N294K mice n = 25, and male Scube3WT n = 33; and at 52 wk: female Scube3N294K/N294K mice n = 12, female Scube3WT n = 8, male
Scube3N294K/N294K mice n = 5, and male Scube3WT n = 11. For CTX-1 measurement at 52 wk, numbers were n = 10 mice for both female
Scube3N294K/N294K mice and Scube3WT mice, male Scube3N294K/N294K mice n = 9, and male Scube3WT mice n = 10. ALB, albumin; ALP, total
alkaline phosphatase; Ca, total inorganic calcium; CHO, cholesterol; CREA, creatinine; CTX-1, carboxy-terminal collagen crosslinks; GLUC,
glucose; Pi, total inorganic phosphate; TG triglycerides; TP, total protein; UA, uric acid.
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17. A C–A transversion at nucleotide position 882 in exon 8 of Scube3
leads to an asparagine to lysine exchange at protein position
294 (N294K). This nonsynonymous sequence variation cosegregated
with the Scube3N294K/N294K phenotype in all 15 testedmutant mice, and
was not conﬁrmed in 10 wild-type littermates and other mice of inbred
C3H, BALB/c, andB6 strains. Subsequently, thismutationwas conﬁrmed
in more than 100 mutant Scube3N294K/N294K mice during maintenance
breeding and excluded in the equal number of wild-type littermates.
The N294K substitution is located within the Ca-binding EGF-like
domain 7 of SCUBE3, which is highly conserved between mouse,
human, zebraﬁsh, and chicken (data not shown). Using the protein
prediction programs PROVEAN (http://provean.jcvi.org; Choi et al.
2012) and PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2), this se-
quence variation was classiﬁed as deleterious or probably damaging
with a score of 0.99.
Phenotypic analysis
A cohort of 15 male and 15 female Scube3N294K/N294K mice and the
respective number of Scube3WTmice were analyzed in the GMC in the
screens for behavior, neurology, nociception, vision and eye, dysmor-
phology, bone and cartilage, energy metabolism, hematology, clinical
chemistry, steroid metabolism, immunology, allergy, cardiovascular
system, lung function, molecular phenotyping, and pathology.
Scube3N294K/N294K mice show skeletal abnormalities and changes in
bone metabolism: In addition to the aforementioned smaller body size,
shorter and kinked tails, and abnormal digit positioning, X-ray analysis
of the skeleton showed no obvious craniofacial abnormalities but de-
tectedmalformations of the thoracic and lumbar vertebrae, and shorter
femora (Figure 1A and Table S2C) in Scube3N294K/N294Kmice that were
independent of the body size reduction. Rib fusions occurred with low
penetrance (3% of observed animals, data not shown). In DEXA anal-
ysis, bone mineral density (BMD) and bone mineral content (BMC)
were signiﬁcantly decreased (Table S2B), but the results might be con-
founded by body weight (Figure 1, B and C). Several parameters in
pQCT-measurements supported the ﬁndings of the DEXA analysis.
The effects were weaker in 12-month-old than in 9-months-old mice
(File S1 and Table S3).
Ca levels at the age of 17 wk were elevated in Scube3N294K/N294K
female mice but this ﬁnding was not conﬁrmed in older animals. Pi
levels were globally decreased in male mice and ALP activities in mice
of both sexes were increased with effects getting weaker with age. At
1 yr of age, Scube3N294K/N294K mice showed a signiﬁcant increase of the
bone resorption marker CTX-1 (Figure 2).
Scube3N294K/N294K mice have defects in bone growth, but not in
embryonic patterning: For further investigation of the observed bone
abnormalities, we analyzed Scube3N294K/N294K mice at newborn and
various embryonic stages by skeletal staining.Multiple hyper-ossiﬁcations
in the axial and appendicular skeleton were detected. In thoracic,
lumbar, and sacral vertebrae of Scube3N294K/N294K mice, ossiﬁcation
center and pedicles were more closed and fused compared to those of
wild-type mice (Figure 3B, asterisks indicate the ossiﬁcation center).
Further, in some thoracic vertebrae, ossiﬁcation centers were split in
mutant mice (Figure 3B, two asterisks in one vertebrae). In the appen-
dicular skeleton, the coracoid processes showed hyper-ossiﬁcation, and
proximal andmiddle phalanges in digit II started to be fused (Figure 3F,
arrowhead and black asterisks). Furthermore, metacarpal, metatarsal,
and tarsal were enlarged due to hyper-ossiﬁcation (Figure 3F and Fig-
ure 3H, white asterisks). These hyper-ossiﬁcation phenotypes were not
detected at embryonic day E15.5 around the time when endochondral
ossiﬁcation starts, but were detected in E17.5 Scube3N294K/N294K embryos
(data not shown), suggesting that malformations of Scube3N294K/N294K
mice are due to defects in bone growth, but not because of disturbed
embryonic patterning as in vertebral segmentation disorders.
Scube3N294K/N294K mice show symptoms pointing to disturbances in
renal function: U, CREA, and K levels, as well as a-amylase activities,
were increased in plasma of Scube3N294K/N294K mice of both sexes
(Table S2B). The ﬁndings were consistent for most parameters over
Figure 3 Skeletal phenotypes of newborn
Scube3N294K/N294K mice. Hyper-ossiﬁcation of en-
tire vertebrae in homozygous Scube3N294K/N294K
mice (B and D) compared to wild-type mice (A
and C). Asterisks in (B) indicate remarkable hy-
per-ossiﬁed vertebrae. Note that split ossiﬁcation
centers were detected in T10 and T11 (two asterisks
in one vertebra). Sternebrae of Scube3N294K/N294K
mice (D) were slightly thicker and longer than ones
of wild-type mice (C). Asterisks in (D) indicate hyper-
ossiﬁed sternebrae. Bones of upper and lower limbs
in homozygous mutants (F and H) were also
hyper-ossiﬁed compared to wild-type (E and
G). Arrowhead indicate ossiﬁed coracoid pro-
cess (E). Asterisks in (F) and (H) show represen-
tative hyper-ossiﬁed metacarpals, metatarsals,
phalanx, and tarsals.
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the whole life period (measured at 12, 24, 36, and 52 wk of age,
Figure 2). In addition, plasma glucose levels, triglyceride, and Pi
concentrations were decreased in both sexes, whereas total protein,
albumin, and cholesterol were decreased only in male mutants
(Table S2B). To follow up these ﬁndings, we analyzed renal function
in metabolic cages. Calculated 24 hr CREA clearance adjusted to
body weight was normal in Scube3N294K/N294K mice, suggesting that
a similar amount of plasma was ﬁltered per g of body mass by the
kidneys of mutant and control mice within 24 hr (Table 1). How-
ever, water uptake and urine production in relation to body mass
(Table 1) as well as food consumption (2.85 6 0.23 vs. 2.02 6 0.35
and 3.18 6 0.57 vs. 2.64 6 0.47 g/24 hr in mutant vs. control males
and females, respectively) were signiﬁcantly higher in Scube3N294K/N294K
mice. Urinary concentrations of electrolytes and U were comparable,
while CREA, protein (total protein and albumin), and glucose concen-
trations were slightly lower, and uric acid level was signiﬁcantly lower, in
Scube3N294K/N294Kmice (data not shown). Consequently, calculated 24 hr
excretion values per 25 g body mass and fractional excretion rates were
signiﬁcantly increased in Scube3N294K/N294K mice for the electrolytes Na,
K, Cl, as well as Ca, U, total protein, albumin, and glucose. Uric acid and
Pi excretion adjusted to body mass was found to be highly variable and
did not signiﬁcantly differ between genotypes (Table 1).
Transcriptome analysis suggests a role of Scube3 in reabsorption
and/or excretion of urine components: We performed transcriptome
analysis of kidney samples from Scube3N294K/N294K mice. Statistical
analysis of gene expression patterns identiﬁed 138 differentially
expressed genes functionally classiﬁed by the following overrepresented
terms: cellular development, movement, and proliferation, as well as
cardiovascular system function, developmental disorder, and renal and
urological disease (Table 2). Additionally, literature-based research
revealed several genes associated with expression in proximal tubules
(Havcr1, Has2, Met, Mep1b, Mme, and Slc29a8), reabsorption of
electrolytes (proximal tubule epithelium: Cldn10 and Slc12a1), and
maintenance of salt/water balance of blood (renal medulla: Acta2,
Adamts1, Ehd3, Kcnj15, and Umod). All these genes were down-
regulated in kidney.
Scube3N294K/N294K mice have hearing deﬁcits, alterations in the
inner and middle ear, and show behavioral abnormalities: Hearing
sensitivitywas assessedby auditorybrainstemresponse (ABR) todifferent
auditory stimuli. There were signiﬁcant differences at clicks and all tested
frequencies; thresholds were increased in Scube3N294K/N294Kmice of both
sexes, with female Scube3N294K/N294Kmice more severely affected (Figure
4A). Further analysis of this ﬁnding revealed alterations in inner and
middle ear preparations. The inner and middle ears appeared
smaller and the ossicles of the middle ear had decreased size and
altered shape. The incus was smaller, and the body and head of the
malleus were especially decreased in size (Figure 4B). The middle
ear cavity, the bulla, part of the temporal bone, had an irregular
shape as well (Figure 4B).
In the open ﬁeld test, Scube3N294K/N294K mice showed clearly de-
creased locomotor and exploratory activity, as indexed by a reduction
in total distance traveled and rearing activity over the course of the
20min test. Movement velocity was also decreased. In terms of anxiety-
related behavior, Scube3N294K/N294K mice spent less time in the center,
entered into the center less often, traveled less distance within this zone,
and exhibited an increased latency to enter the center (Figure 5 and
Table S2B). In the modiﬁed hole-board test, maximum and angular
velocity were decreased in Scube3N294K/N294Kmice as well as the latency
to engage in risk assessment by the male mutant mice (Table S2B).
In a general observation series according to the modiﬁed SHIRPA
protocol, we also observed reduced locomotor activity, particularly in
female Scube3N294K/N294K mice. In addition, we found a reduction in
n Table 1 Renal function analysis
Males Females 2-Way ANOVA (P Value)
Parameter
Scube3WT
n = 12
Scube3N294K/N294K
n = 12
Scube3WT
n = 10
Scube3N294K/N294K
n = 12 Genotype Sex
Genotype ·
Sex
Water uptake/25 g BW
(g/24 hr)
3.68 6 0.81 6.01 6 1.54 4.65 6 1.88 6.88 6 1.53 , 0.001 0.039 0.910
Urine excretion/25 g BW
(g/24 hr)
0.59 6 0.31 1.1 6 0.43 0.89 6 0.57 1.20 6 0.55 0.004 0.201 0.412
Creatinine clearance/25g BW
(mg/24 hr)
583 6 305 548 6 265 812 6 564 606 6 191 0.246 0.168 0.409
Na/25 g BW (mmol/24 hr) 102 6 50 208 6 59 181 6 105 205 6 102 , 0.001 0.004 0.803
K/25 g BW (mmol/24 hr) 228 6 109 444 6 131 392 6 237 539 6 192 , 0.001 0.014 0.510
Cl/25 g BW (mmol/24 hr) 125 6 62 262 6 71 245 6 154 364 6 116 , 0.001 , 0.001 0.758
Ca/25 g BW (mmol/24 hr) 1.2 6 0.6 2.3 6 0.8 2.7 6 1.5 4.1 6 1.4 , 0.001 , 0.001 0.611
Urea/25 g BW (mg/24 hr) 60 6 28.6 112 6 31.9 111 6 65.3 155 6 44 0.099 , 0.001 0.671
Total protein/25 g BW
(mg/24 hr)
8.2 6 3.5 11.8 6 3.3 2.8 6 1.9 3.7 6 1.9 0.009 , 0.001 0.107
Albumin/25 g BW (mg/24 hr) 98 6 39 122 6 31 108 6 44 153 6 50 0.008 0.109 0.411
Glucose/25 g BW (mg/24 hr) 210 6 90 310 6 94 427 6 204 501 6 121 0.030 , 0.001 0.742
FE Na (%) 0.13 6 0.05 0.30 6 0.10 0.18 6 0.05 0.33 6 0.08 , 0.001 0.149 0.656
FE K (%) 9.7 6 3.1 20.4 6 6.2 13.2 6 3.3 21.7 6 4.8 , 0.001 0.082 0.422
FE Cl (%) 0.22 6 0.08 0.52 6 0.17 0.31 6 0.08 0.57 6 0.13 , 0.001 0.061 0.672
FE Ca (%) 0.10 6 0.03 0.20 6 0.07 0.15 6 0.02 0.28 6 0.08 , 0.001 , 0.001 0.343
FE urea (%) 19 6 4.9 34 6 10.4 28 6 6.6 41 6 10.5 , 0.001 0.002 0.708
FE total protein (%) 0.007 6 0.003 0.012 6 0.006 0.027 6 0.009 0.045 6 0.012 , 0.001 , 0.001 0.016
FE albumin (%) 0.00006 6 0 0.00009 6 0 0.00007 6 0 0.00010 6 0 , 0.001 0.334 0.596
FE glucose (%) 0.029 6 0.009 0.043 6 0.010 0.019 6 0.007 0.031 6 0.010 , 0.001 , 0.001 0.720
ANOVA, analysis of variance; Na, sodium; K, potassium; Cl, chloride; Ca, calcium; FE, calculated fractional excretion rate.
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grip strength, which was also inﬂuenced by the body mass reduction
(Table S2, B and C and Figure 5).
Scube3N294K/N294K mice have altered function in energy
metabolism: Scube3N294K/N294K mice had signiﬁcantly reduced body
mass, and considerably lower absolute fat and lean mass (Table S2C).
They also showed a signiﬁcant shift in body composition, particu-
larly with regards to decreased lean mass when adjusted to body
mass (Figure 6). Interestingly, the relations between body mass and
fat content, as well as body mass and lean mass, were signiﬁcantly
different between genotypes (Table S2C), indicating a systematic
effect on body composition. Scube3N294K/N294K mice had signiﬁcantly
lower glucose, triglyceride, NEFA, and glycerol concentrations in
plasma (Table S2B). In the glucose tolerance test, basal fasting glucose
levels were signiﬁcantly decreased in Scube3N294K/N294Kmice. AUC (area
under the curve) values were decreased, which indicates an improved
n Table 2 Functional classiﬁcation of regulated genes in kidney
Biological Functions and Disease Genes # Genes
Cellular development Blk, Casp3, Ccr1, Chek1, Commd3-Bmi1, Cxcl12, Eif4g2, Ereg, Foxc1,
Gabpa, Has2, Havcr1, Hif1a, Hmox1, Hoxa10, Id4, Igf2, Jdp2, Met,
Rasgrp1, Scel, Srpx2, Tcf21, Tert, Tnn
25
Cellular movement Adamts1, Arhgap35, Ccr1, Cxcl12, Ereg, Foxc1, Fpr3, Has2, Hif1a, Hmox1,
Igf2, Ltc4s, Mep1b, Met, Mme, Plec, Ppt2, Rasgrp1, Sema6d, Slc12a1,
Srpx2, Tgfbr3, Tnn, Umod, Vav3
25
Cardiovascular system function A4gnt, Adamts1, Casp3, Chm, Cxcl12, Ehd3, Foxc1, Has2, Hif1a, Hmox1,
Hoxa10, Ift57, Igf2, Lefty2, Met, Plec, Srpx2, Tcf21, Tert, Tgfbr3, Tnn,
Trpc1, Usp8, Vav3
24
Nervous system function Arhgap35, Casp3, Chm, Commd3-Bmi1, Cxcl12, Fa2h, Faim2, Gpr37,
Hif1a, Hoxa10, Ift57, Igf2, Madd, Met, Plec, Ppt2, Rgs7, Sh3gl2, Slitrk6,
Vav3
20
Cell death and survival Adamts1, C8orf44-Sgk3/Sgk3, Casp3, Ccr1, Chek1, Commd3-Bmi1,
Cxcl12, Fa2h, Hif1a, Hmox1, Id4, Igf2, Jdp2, Met, Tert, Top1, Umod,
Usp8
18
Neurological disease Casp3, Commd3-Bmi1, Gnat1, Gng7, Grik1, Hmox1, Id4, Igf2, Kcnip2,
Man1a1, Mdh1, Ppp1cb, Ppt2, Ranbp1, Sgtb, Sh3gl2, Top1
17
Cancer Acta2, Bdh1, Gpr37, Havcr1, Hif1a, Hmox1, Id4, Igf2, Lefty2, Mdh1, Met,
Tert, Tgfbr3
13
Cell cycle Chek1, Commd3-Bmi1, Has2, Havcr1, Hmox1, Hoxa10, Id4, Igf2, Met,
Slbp, Tert, Trpc1, Usp8
13
Cellular growth and proliferation Chek1, Cxcl12, Ereg, Ghrhr, Has2, Hif1a, Hoxa10, Id4, Lmo3, Met, Tert,
Top1
12
Developmental disorder Chm, Commd3-Bmi1, Eif4g2, Has2, Hif1a, Hmox1, Ift57, Igf2, Ranbp1,
Sh3gl2, Slc12a1, Usp8
12
Renal and urological disease Ccr1, Ereg, Havcr1, Hif1a, Igf2, Lmo3, Met, Mme, Slc39a8, Tert 10
Shown are signiﬁcantly (P , 0.05) enriched terms from the “biological functions and disease” analysis in Ingenuity Pathway Analysis.
Figure 4 (A) Mild conductive hearing loss; asterisks mark genotype effect of both sexes together.  P , 0.05,  P , 0.01,  P , 0.001. (B)
Abnormalities in inner ear development. Upper panel: depiction of smaller and malformed ossicles. The ambos (incus) has a different shape and
the body of the hammer (malleus) is narrowed (arrow) and the head surface decreased. Lower panel: the whole inner and middle ear was reduced
in size and, besides the alterations of the ossicles (arrow pointing toward the hammer, malleus), the auditory cavity (bulla) has an irregular shape
(arrows). WT, wild-type.
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glucose tolerance in Scube3N294K/N294K mice (Table S2B). We applied
indirect calorimetry to investigate energy expenditure, substrate use, and
locomotor activity under home-cage conditions, and found rearing be-
havior decreased during the 21 hr test phase. Nomajor effects on energy
turnover could be detectedwhenVO2was adjusted to bodymass (Table
S2C). In a separate test, food consumption and gastro-intestinal func-
tions of Scube3N294K/N294Kmice were monitored over 5 d in single caged
animals.We could not detect considerable effects on food intake, energy
assimilation, and the efﬁciency of energy extraction from food.
Scube3N294K/N294K mice show mild alterations in cardiovascular
parameters, but no hints of deﬁcits in heart performance or
conduction: Echocardiography and electrocardiography revealed sev-
eral mild alterations in Scube3N294K/N294Kmice (decreased interventric-
ular septum width, decreased left ventricular posterior wall thickness,
decreased left ventricular mass, and prolonged QRS interval duration
mainly in male Scube3N294K/N294K mice, as well as decreased di-
astolic ventricular dimension and decreased respiration rate in female
Scube3N294K/N294K mice, Table S2A). We found a signiﬁcantly lower
Figure 5 Analysis of Scube3N294K/N294K mice in the Open Field test and grip strength analysis. Data for distance traveled (A), number of rears (B),
and percent time spent in center (C) are shown over the 20 min test interval. Grip strength (four paw measurement) is plotted vs. body weight (D)
(green, Scube3N294K/N294K males; yellow, Scube3N294K/N294K females; blue, Scube3WT males; and red, Scube3WT females).
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heart weight of Scube3N294K/N294K mice as compared to sex-matched
controls (also when normalized to tibia length). However, no alter-
ations were found in heart performance or conduction, and thus
there was no clear hint for a physiologically relevant constraint of
cardiovascular function due to the mutation. Further in line, the
observed alterations may be confounded by the reduced body weight
of Scube3N294K/N294K mice.
Further tested organ functions are normal in Scube3N294K/N294K
mice: The analysis of immunologically relevant parameters revealed
nomajor changes.We observed tendencies toward decreased frequency
of L-selectin expressing cells within T cell populations and increased
frequency of CD11b-expressing cells within the NK cell compartment
(Table S2A). We did not detect any changes in hematological param-
eters. Eye morphology and vision were as expected for the genetic
background (C3HeB/FeJ). There were no major genotype effects on
prepulse inhibition response or pain perception. No differences were
detected for rotarod performance. The analysis of transepidermal water
loss (TEWL) from the skin of the mice did not reveal genotype-speciﬁc
differences, while hair structure and coat appeared normal. There
were no alterations in lung function. Scube3N294K/N294K mice at the
age of 21 wk did not present additional histopathological alterations.
DISCUSSION
Weidentiﬁed anENU-derivedmouse line carrying amissensemutation
in Scube3 (NM_001004366.1:c.882C . A, NP_001004366.1:p.
Asn294Lys), and characterized the Scube3N294K/N294K mutant mouse
in detail in the GMC (Hrabé de Angelis et al. 2015; Gailus-Durner
et al. 2005; Fuchs et al. 2012). As shown previously in a Scube3 reporter
mouse line, targeted replacement of exons 2 and 3 by a lacZ-cassette
demonstrated early expression of the gene in craniofacial, limb, and
neural tube tissues (Xavier et al. 2010). However, these mice, as well as
SCUBE3 loss-of-function mice, developed normally and did not
show overt phenotypic alterations (Xavier et al. 2013, 2010) whereas
Scube3N294K/N294K mice exhibited alterations in several organ sys-
tems. One reason for this discrepancy might be owed to the different
genetic backgrounds of the mice in these studies. However, a more
likely explanation is the redundancy of Scube family members, which
might compensate the loss of SCUBE3 in the null mutant (Xavier et al.
2013), and the nature of the mutation in the Scube3 mouse model de-
scribed here. The amino acid exchange in Scube3N294K/N294K mice lies
within the EGF-like domain 7 that follows the consensus sequence
D/N-X-D/N-E/Q-Xm-D/N-Xn-Y/F for Ca-binding EGF-like domains
(cbEGFs, Figure 7). These domains are known to mediate protein–
protein and protein–carbohydrate interactions in a Ca-dependent
manner (Downing et al. 1996). They are also structurally important for
several cellular processes such as extracellular matrix architecture or
speciﬁcation of cell fates (Downing et al. 1996). For example, missense
mutation of conserved amino acids in cbEGFs of ﬁbrillin 1 (FBN1) are
causative for Marfan syndrome due to Ca2+-dependent misfolding of
the protein (Whiteman et al. 2007). Likewise, the amino acid exchange
in the cbEGF domain 7 in Scube3N294K/N294K mice might lead to a
reduced Ca2+-binding capacity and/or to conformational changes,
which in turn could negatively interfere with both homo- and hetero-
meric interaction of SCUBE proteins (Wu et al. 2004; Yang et al. 2002),
posttranslational processing (Wu et al. 2011), and interaction with
transforming growth factor-b and hedgehog signaling (Johnson et al.
2012; Wu et al. 2011).
Scube3 is expressed in the cartilaginous primordia of the skeleton
and regions of intramembranous bone formation in the developing
craniofacial region (Haworth et al. 2007). Nevertheless, besides middle
ear abnormalities, Scube3N294K/N294K mice did not show any further
craniofacial abnormalities, suggesting that SCUBE3 is dispensable for
craniofacial development (Xavier et al. 2013) or that the respective
functions may be assigned to regions upstream of cbEGF7 of SCUBE3.
However, the Scube3N294K/N294K mutation directly affects bone mor-
phology and bone metabolism. Scube3N294K/N294K mice had a signiﬁ-
cant reduction in body size and weight. Interestingly, GWAS found
SCUBE3 SNPs among adult and pediatric height-associated loci
(Gudbjartsson et al. 2008; Zhao et al. 2010), as well as in pigs, associated
with body height, body length, and rump circumference (Wang et al.
2014). The inﬂuence of the Scube3 mutation on bone metabolism was
expressed by increased ALP activities and CTX-1 values in plasma, as
well as by decreased BMD and BMC in DEXA and pQCT analysis.
These data are supported by the ﬁnding that SCUBE3 is expressed in
Figure 6 (A) Fat mass plotted against body mass (green, Scube3N294K/N294K males; yellow, Scube3N294K/N294K females; blue, Scube3WT males;
and red, Scube3WT females). (B) Lean mass plotted against body mass (green, Scube3N294K/N294K males; yellow, Scube3N294K/N294K females; blue,
Scube3WT males; and red, Scube3WT females).
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early osteoblasts and long bones (Wu et al. 2004). Interestingly, the
human SCUBE3 gene is located on chromosome 6p21.3, which was
discussed to be associated with Paget disease of bone 1 (PDB1) (Wu
et al. 2004; Fotino et al. 1977; Tilyard et al. 1982; Good et al. 2002).
Although PDB is characterized by late onset and mostly focal bone
abnormalities due to increased bone turnover (Ralston et al. 2008),
mouse models for genes known to be mutated in PDB, such as
Tnfrsf11a for PDB2 (OMIM 603499) and Sqstm1 for PDB3 (OMIM
601530), have bone abnormalities already at birth (Dougall et al.
1999; Li et al. 2000) or not until adulthood (Kapur et al. 2004; Durán
et al. 2004; Daroszewska et al. 2011). Interestingly, cases of PDB
were described to be associated with raised ALP activities and deaf-
ness (Tan et al. 2014). Therefore, we suggest Scube3N294K/N294K mice
as a new model for further studies on PDB1.
SCUBE3 maps to a region that was associated with progressive
bilateral hearing loss of the mid and high frequencies (DFNA31,
OMIM %608645) (Snoeckx et al. 2004). The results of the ABR-
hearing assessment and the morphological analysis of the middle
ears of Scube3N294K/N294K animals indicate conductive hearing loss.
In Scube3N294K/N294K mice, hearing loss might be a consequence of
retarded development of middle ear cavity and ossicle malforma-
tions. By contrast, Xavier et al. (2013) did not observe any gross
abnormalities in the (inner) ears of Scube32/2 mice at the age of
E17.5. Since background-speciﬁc genetic modiﬁers play an impor-
tant role in the development of inner ears (Kiernan et al. 2007), the
differences in the genetic background could be the reason for the
different observations in the two studies.
The kidneys play a central role in the regulation of mineral homeo-
stasis and chronic kidney disease (CKD) is associated with bone
metabolic disease. However, the regulatory pathways involved are still
not fully understood (reviewed in Hu et al. 2013; Peacock 2010;
Razzaque 2011; Rowe 2012). Elevated plasmaU andCREA levels found
in Scube3N294K/N294K mice hint toward possible effects on renal func-
tion. We found increased electrolyte and water excretion, but no alter-
ation of CREA clearance. These ﬁndings could be a sign of altered renal
tubular function or might be a consequence of increased electrolyte
consumption due to higher food uptake causing an upregulation of
excretory mechanisms. The annotations of differentially expressed
genes in kidney with reabsorption of electrolytes and salt/water balance
indicate effects on tubular reabsorption. Acta2 (Tanabe et al. 2012),
Adamts1 (Schrimpf et al. 2012), Ehd3 (George et al. 2011), Kcnj15
(Derst et al. 1998), and Umod (Rampoldi et al. 2011) are annotated
with expression in renal medulla and salt/water balance, and Clnd10
(Krug et al. 2012), Havcr1 (Adiyanti and Loho 2012), Has2 (Michael
et al. 2011), Mep1b (Oneda et al. 2008), Met (Zhou et al. 2013), Mme
(Van der Hauwaert et al. 2013), Slc12a1 (Yang et al. 1996), and Slc39a8
(Nebert et al. 2012) are associated with electrolyte reabsorption in the
proximal tubules. Together these ﬁndings hint toward a possible role of
Scube3 in kidney development and function, supported by the expres-
sion of Scube3 in the developing kidney (Haworth et al. 2007), or might
be related to secondary effects on the regulation of kidney function.
The human SCUBE3 protein is involved in hedgehog and TGF-b1
signaling (Xavier et al. 2013; Haworth et al. 2007; Yang et al. 2007;
Johnson et al. 2012) but, so far, nothing is known about SCUBE3
signaling in this network in mice. Transcriptome proﬁling analysis of
kidney from Scube3N294K/N294K mice identiﬁed potential down-stream
targets of SCUBE3 that are annotated to TGF-b1 signaling [C1qtnf3
(Hofmann et al. 2011), Foxc1 (Xu et al. 2012),Has2 (Davies et al. 2005),
Jdp2 (Mito et al. 2013), Kcnip2 (Kaur et al. 2013), Lefty2 (Saijoh et al.
2000; Arganaraz et al. 2012), Tgfbr3 (Walker et al. 2011), and Tnn
(Alejandre Alcázar et al. 2011)]. Reduced expression of all these genes
gives evidence for a supportive role of SCUBE3 within the TGF-b1
signaling pathway by binding to transforming growth factor b receptor
2 (TGFBR2) (Yang et al. 2007).
Althoughwedidnot observe structural defects ofmuscle tissue in the
pathological examination, the repeated ﬁndings of reduced locomotor
and rearing activity as well as movement velocity might be indications
for functional defects, whichmight also be associated with an abnormal
muscle energy metabolism. Indeed, very recent ﬁndings from detailed
analysis of zebraﬁsh scube3 suggest that its gene function is crucial for
fast-ﬁber myogenesis (Tu et al. 2014). Still, decreased activity and
movement velocity could also be due to the described early develop-
mental expression of Scube3 in the neural tube (Haworth et al. 2007).
SCUBE3 expression was observed in human cultured coronary
smooth muscle cells and at low levels in the heart (Wu et al. 2004),
and its overexpression led to cardiac hypertrophy in transgenic mice
(Yang et al. 2007). Whereas young Scube3 transgenic mice appeared
Figure 7 Scube3N294K/N294K mice are homozygous for a (C) to (A)
point mutation at nucleotide position 882 that leads to an asparagine
to lysine exchange at protein position 294 (N294K) in exon 8 of Scube3
(A). The mutation affects the calcium-binding EGF-like domain VII (B),
which might have effects on the capabilities to form homo- or hetero-
dimers and block TGFb/Hedgehog signaling (C), which causes pheno-
typic alterations in bone development and homeostasis, hearing ability,
renal function, energy metabolism, neurological functions, and behavior.
EGF, epidermal growth factor; TGFb, transforming growth factor b.
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phenotypically normal but showed abnormal repolarization ECG pat-
terns as well as thickening of left-ventricular septum and posterior
wall thickness when analyzed at 8 months of age (Yang et al. 2007),
Scube3N294K/N294K mice showed only very mild alterations in cardiac
parameters of our phenotypic analysis. Possibly, they were too young
for manifestation of a severe cardiac dysfunction.
In this study, we characterized the ﬁrst Scube3 mutant mouse line
with phenotypic alterations, suggesting a role of Scube3 in bone me-
tabolism and morphology, hearing, and renal function. The observed
morphological abnormalities of the skeleton, impaired bone metabo-
lism, and hearing impairments correlate with the rare metabolic bone
disorder PDB, associated with the chromosomal region of human
SCUBE3. Further phenotypic alterations were observed in energy
metabolism parameters, in behavior, and neurological functions
(Figure 7). This new mouse model will help us to better understand
SCUBE3 function and diseases related to Scube3 gene mutations.
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